Structure of the BRCT Repeat Domain of MDC1 and Its Specificity for the Free COOH-terminal End of the γ-H2AX Histone Tail*
暂无分享,去创建一个
[1] J. Glover,et al. Interactions between BRCT repeats and phosphoproteins: tangled up in two. , 2004, Trends in biochemical sciences.
[2] Junjie Chen,et al. DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains , 2004, Molecular and Cellular Biology.
[3] Drew M. Lowery,et al. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer , 2004, Nature Structural &Molecular Biology.
[4] J. Glover,et al. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1 , 2004, Nature Structural &Molecular Biology.
[5] Yigong Shi,et al. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. , 2004, Molecular cell.
[6] Junjie Chen,et al. Phosphopeptide Binding Specificities of BRCA1 COOH-terminal (BRCT) Domains* , 2003, Journal of Biological Chemistry.
[7] Michael B Yaffe,et al. BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting , 2003, Science.
[8] Georges Mer,et al. The BRCT Domain Is a Phospho-Protein Binding Domain , 2003, Science.
[9] Christophe E. Redon,et al. Characteristics of γ-H2AX foci at DNA double-strand breaks sites , 2003 .
[10] J. Bartek,et al. MDC1 is required for the intra-S-phase DNA damage checkpoint , 2003, Nature.
[11] Stephen J. Elledge,et al. MDC1 is a mediator of the mammalian DNA damage checkpoint , 2003, Nature.
[12] J. Glover,et al. Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation* , 2003, The Journal of Biological Chemistry.
[13] L. Serpell,et al. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor , 2002, The EMBO journal.
[14] D. Livingston,et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. , 2002, Genes & development.
[15] J Navaza,et al. Implementation of molecular replacement in AMoRe. , 2001, Acta crystallographica. Section D, Biological crystallography.
[16] J. Glover,et al. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1 , 2001, Nature Structural Biology.
[17] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[18] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[19] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[20] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[21] Thomas Terwilliger,et al. SOLVE and RESOLVE: automated structure solution, density modification and model building. , 2004, Journal of synchrotron radiation.
[22] Richard J Morris,et al. ARP/wARP and automatic interpretation of protein electron density maps. , 2003, Methods in enzymology.
[23] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.